Uranium Energy Corporation is apparently getting more value than expected for Dennison Mines. UEC is a buy, flat out. Beyond our normal bullish take on nuclear in general, 9 reactors have been restarted in Japan. How much impact will that have on UEC’s share price? Probably not at all, but it gets the ball rolling. UEC closed Friday at $4.26.

1. USOI - $4.48/share, ex-div 8/19. The return is listed at a whopping 38.64% return! This is thankfully misleading, and merely reflective of the price being abnormally low. Credit Suisse is probably super evil, but they’re also super reliable when it comes to reliable returns on their investment products.
   

   USOI is Oil. Sweet, delicious, oil. Operating as a partnership, the monthly distribution comes in the form of returned capital. A return of capital is not a taxable transaction. (You would eventually pay taxes, after you ROI, on your gains).
   

2. PSIL - $3.28 , this is a psychedelics ETF. They’re involved in medical and recreational psychedelic drugs, such as LSD and psilocybin mushrooms. If it’s legal, it’s probably in this ETF.
   
   We haven’t dug deep enough to be certain, but it appears they do not get involved with cannabis or CBD. To us, this is a plus. Don’t buy weed stocks.
   

3. SNDL -$2.53/share, weekly options. Sundial is a weed stock. Now hold on, I know, red flags. The security underwent a 1:10 reverse split. This makes the options slightly more worthwhile, at a time where we feel the stock price is pretty much as low as it’s going to go.

   There’s a couple other companies seeing volatility and upward momentum, but that worries us. Weed stocks are already generally a bad idea.
   

4. ACAD - $16.44/share, weekly options. ACADIA Pharmaceuticals has experienced some setbacks lately, at a time when the stock price is already reasonably low.
   
   While the longevity of this security is cause for caution, the company itself is solid enough to persist for some time to come. In the meantime, we’re happy to write covered calls against LEAPS on this one.
   

5. PBR.A - $13.46/share, ex-div 8/12, 46.78% annualized return. Now, while we’ll disclaim this is reflective of price volatility, a solid 20% return can still be expected from PetroBras for a few years.
   

   If your brokerage account does not permit the trade of Preferred Stocks, the common stock PBR is $14.45 with a 43% return, ex-div on 8/12. The common stock has weekly options.